本文選題：mir-1271 + RTEF-1　； 參考：《鄭州大學(xué)》2015年碩士論文

【摘要】：背景與目的胃癌是我國(guó)胃腸道腫瘤中常見(jiàn)的惡性腫瘤,具有惡性程度高、易轉(zhuǎn)移和死亡率高的特點(diǎn)。因此,深入研究胃癌發(fā)病的機(jī)制從而尋找到新的早期診斷和有效的治療方法,是擺放在我國(guó)醫(yī)療工作者面前的重要問(wèn)題。胃癌發(fā)病率隨患者年齡增加而升高,其發(fā)病高峰年齡為60歲左右。較之青年胃癌,老年胃癌患者表現(xiàn)出組織學(xué)分化程度高、生物學(xué)侵襲性弱、腫瘤惡性程度低的臨床特點(diǎn)。老年胃癌與青年胃癌在生物學(xué)行為上的這種差別提示兩組胃癌在各自的發(fā)病及發(fā)展過(guò)程中存在著不同的分子調(diào)節(jié)機(jī)制。但是,目前尚不清楚是什么分子機(jī)制導(dǎo)致了老年胃癌具有相對(duì)低危的生物學(xué)特性。因此,研究老年和青年胃癌間存在的不同分子調(diào)節(jié)機(jī)制,有利于我們進(jìn)一步深入了解胃癌發(fā)生、發(fā)展的過(guò)程,對(duì)于胃癌的個(gè)體化預(yù)防和治療具有重要的理論指導(dǎo)意義。惡性腫瘤普遍具有高度異質(zhì)性的特點(diǎn),既往研究結(jié)果顯示:老年胃癌是胃癌患者中的一個(gè)主要患者群體,其臨床病理特征不同于青年胃癌,反映在:女性發(fā)病率顯著低、組織學(xué)分化程度高、生物學(xué)侵襲性弱、腫瘤惡性度低等。且老年胃癌遺傳傾向低于青年胃癌,表現(xiàn)為有胃癌家族史的患者明顯較青年胃癌組低。分子學(xué)水平上,既往研究也發(fā)現(xiàn)老年胃癌及青年胃癌患者間的基因組譜差異,另外介導(dǎo)細(xì)胞黏附和維持細(xì)胞骨架的E-鈣黏素和β-Catein表達(dá)水平和標(biāo)志著DNA錯(cuò)配修復(fù)功能缺陷的微衛(wèi)星不穩(wěn)定性(MSI)等也在兩組胃癌間存在著明顯的差異。但是,前期的研究多止步于觀察到上述差異,而缺少對(duì)其內(nèi)在精確分子機(jī)制的研究。RTEF-1(Related Transcriptional Enhancer Factor-1,轉(zhuǎn)錄增強(qiáng)因子-1相關(guān)基因)來(lái)自轉(zhuǎn)錄增強(qiáng)子家族(Transcriptional Enhancer Factor,TEF)。1996年Stewart等人從心肌細(xì)胞中首次成功克隆并編碼,隨后其家族的其他成員被不斷發(fā)現(xiàn)。目前已知該家族成員包括四個(gè):TEF-1,RTEF-1,DTEF-1和ETF,該家族擁有一個(gè)共同的高度保守的DNA結(jié)合域,可以結(jié)合到基因啟動(dòng)子M-CAT原件上發(fā)揮其調(diào)節(jié)作用。RTEF-1作為轉(zhuǎn)錄增強(qiáng)子家族重要的組成部分,既往的研究多集中于其在內(nèi)皮細(xì)胞和血管生成中的調(diào)節(jié)作用。Che P等人既往的研究結(jié)果證實(shí)了Mir-125a-5p通過(guò)下調(diào)RTEF-1可以導(dǎo)致老年小鼠血管生成障礙。鑒于血管生成和腫瘤的密切關(guān)系,近來(lái)RTEF-1在腫瘤形成中的作用同樣引起了關(guān)注。我們提出假設(shè):RTEF-1及相關(guān)調(diào)控因子在老年胃癌及青年胃癌中的表達(dá)是否存在差異,這種差異是否與老年胃癌和青年胃癌間的組織學(xué)分化程度、生物學(xué)侵襲性及腫瘤惡性程度的不同有關(guān)。目的:探討RTEF-1及其上游調(diào)控基因在老年胃癌及青年胃癌中的表達(dá)是否存在差異及其意義。材料與方法1.研究對(duì)象及標(biāo)本采集:標(biāo)本采集于鄭州大學(xué)第一附屬醫(yī)院胃腸外科2014年7月至2015年1月期間進(jìn)行胃癌根治術(shù)的患者。納入標(biāo)準(zhǔn):術(shù)前胃鏡病理提示為胃惡性腫瘤,計(jì)算機(jī)斷層掃描(computed tomography,CT)等檢查進(jìn)行術(shù)前分期,提示患者可以行標(biāo)準(zhǔn)胃癌根治術(shù),術(shù)后病理證實(shí)為胃癌中的低分化腺癌,術(shù)前未進(jìn)行化療,放療及中西醫(yī)結(jié)合等抗腫瘤治療。本實(shí)驗(yàn)經(jīng)我院道德倫理委員會(huì)的批準(zhǔn),而且經(jīng)過(guò)患者知情同意并簽署知情同意書(shū)。2.自Microarray數(shù)據(jù)結(jié)果中分析老年胃癌和青年胃癌中存在差異表達(dá)的mi RNAs;發(fā)現(xiàn)在老年胃癌及青年胃癌中表達(dá)存在明顯差異的mi RNA,RT-q PCR驗(yàn)證;3.分別采用RT-q PCR、Western Blot技術(shù)檢測(cè)RTEF-1在老年胃癌及青年胃癌原代細(xì)胞中的m RNA蛋白水平表達(dá)并進(jìn)行比較。4.所有實(shí)驗(yàn)結(jié)果數(shù)據(jù)均采用SPSS17.0軟件進(jìn)行分析。以P0.05作為差異有統(tǒng)計(jì)學(xué)意義的檢驗(yàn)標(biāo)準(zhǔn)。結(jié)果1.mir-1271在老年胃癌和青年胃癌中均含量豐富且變化相對(duì)明顯;2.老年胃癌細(xì)胞中RTEF-1蛋白表達(dá)較青年胃癌減少;3.老年胃癌細(xì)胞中mir-1271表達(dá)是青年胃癌的3.2倍;結(jié)論老年胃癌及青年胃癌中mir-1271及RTEF-1存在差異性表達(dá),這種差異可能是導(dǎo)致老年胃癌及青年胃癌在組織學(xué)分化程度、生物學(xué)侵襲性及腫瘤惡性程度存在差異的重要分子機(jī)制。
[Abstract]:Background and objective gastric cancer is a common malignant tumor of the gastrointestinal tract in China. It has the characteristics of high malignancy, easy transfer and high mortality. Therefore, it is an important problem placed in front of the medical workers in our country to study the pathogenesis of gastric cancer so as to find a new early diagnosis and effective treatment method. The age of the patients increased and the peak age was about 60 years old. Compared with the young gastric cancer, the elderly patients with gastric cancer showed high histological differentiation, weak biological invasiveness and low malignancy. This difference in biological behavior between the aged and the young gastric cancer suggests that the two groups of gastric cancer are in their respective pathogenesis and hair. There are different molecular mechanisms in the process. However, it is not clear what molecular mechanism leads to the relatively low risk of biological characteristics in elderly gastric cancer. Therefore, the study of different molecular mechanisms in the elderly and young gastric cancer is helpful for us to further understand the occurrence and development of gastric cancer and to the stomach. The individualized prevention and treatment of cancer have important theoretical guiding significance. The malignant tumor has the characteristics of high heterogeneity. The previous research results show that the elderly gastric cancer is a major group of patients with gastric cancer, whose clinicopathological features are different from those of young gastric cancer, which are reflected in the low incidence of female and high degree of histological differentiation. The genetic tendency of the old gastric cancer is lower than that of the young gastric cancer, and the patients with the family history of gastric cancer are obviously lower than those of the young gastric cancer group. The expression level of E- calcarin and beta -Catein and the microsatellite instability (MSI) indicating the functional defect of DNA mismatch repair (MSI) were also significantly different between the two groups of gastric cancers. However, the previous study stopped to observe the above differences, but there was a lack of.RTEF-1 (Related Transcriptional Enhancer) for its intrinsic precise molecular mechanism. Factor-1, -1 related genes from the transcription enhancer family (Transcriptional Enhancer Factor, TEF).1996 Stewart et al. Stewart et al. The first successful cloning and encoding from the cardiac myocytes, and then the other members of the family are constantly discovered. Now the family members are known to include four: TEF-1, RTEF-1, DTEF-1 and ETF, the family embraced There is a common highly conservative DNA binding domain that can be combined with the gene promoter M-CAT to play its regulatory role.RTEF-1 as an important component of the transcription enhancer family. Previous studies have concentrated on its regulatory role in endothelial cells and angiogenesis, and the previous results of.Che P, et al., confirmed that Mir-125a-5p Down regulation of RTEF-1 can lead to angiogenic disorders in old mice. In view of the close relationship between angiogenesis and tumor, the recent role of RTEF-1 in tumor formation is also concerned. We hypothesized: whether there is a difference in the expression of RTEF-1 and related regulatory factors in old and young gastric cancer, whether this difference is with the elderly Histological differentiation, biological invasiveness and tumor malignancy of gastric cancer and young gastric cancer. Objective: To investigate whether the expression of RTEF-1 and its upstream regulatory genes in old gastric cancer and young gastric cancer are different and its significance. Materials and methods 1. research objects and specimen collection: specimen collection at the first of Zhengzhou University Patients undergoing radical gastrectomy for gastric cancer from July 2014 to January 2015 of the affiliated hospital were included in the criteria: preoperative gastroscopic pathological hints for gastric malignant tumor, computed tomography (computed tomography, CT) and other examinations for preoperative staging, suggesting that patients can be treated with standard radical gastrectomy, and the postoperative pathology proved to be a low score in gastric cancer. Adenocarcinoma, chemotherapy, radiotherapy and combination of traditional Chinese and Western medicine were not performed before operation. This experiment was approved by the ethics committee of our hospital, and after the informed consent of the patients and the signing of the informed consent form.2. from the Microarray data, the differential expression of MI RNAs in old gastric cancer and young gastric cancer was analyzed, and it was found in old gastric cancer and Mi RNA, RT-q PCR, and RT-q PCR, Western Blot technology were used to detect the expression of M RNA protein in old gastric cancer and young gastric cancer cells by RT-q PCR and Western Blot, respectively, and the results of all experimental data were analyzed. Results 1.mir-1271 was rich in both old and young gastric cancer. The expression of RTEF-1 protein in 2. elderly gastric cancer cells was less than that in young gastric cancer, and the expression of mir-1271 in 3. old gastric cancer cells was 3.2 times as high as that of young gastric cancer. Conclusion there were differences in mir-1271 and RTEF-1 in old gastric cancer and young gastric cancer. Sexual expression, which may be an important molecular mechanism that leads to differences in histological differentiation, biological invasiveness and malignancy of old and young gastric cancer.
【學(xué)位授予單位】：鄭州大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類(lèi)號(hào)】：R735.2

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 于揚(yáng),趙代偉,王黔,沈祖楹;48例老年胃癌臨床分析[J];貴州醫(yī)藥;2000年05期

2 陳波,韓幸,趙穎;青年與老年胃癌臨床及病理分析[J];華西醫(yī)學(xué);2000年02期

3 張琴陽(yáng),常柏玲,蔣新建,張志明;老年胃癌69例臨床病理分析[J];陜西腫瘤醫(yī)學(xué);2000年03期

4 黃富麟;老年胃癌診治進(jìn)展[J];實(shí)用老年醫(yī)學(xué);2001年03期

5 王青,劉霞萍;老年胃癌109例臨床分析[J];實(shí)用老年醫(yī)學(xué);2001年06期

6 王正悅;老年胃癌55例的外科治療[J];鐵道醫(yī)學(xué);2001年01期

7 唐任斌,石榮賜;老年胃癌出血64例臨床分析[J];廣西醫(yī)科大學(xué)學(xué)報(bào);2002年05期

8 葉超然;中青年胃癌與老年胃癌臨床及病理分析[J];廣西醫(yī)學(xué);2002年07期

9 張中德,羅志勇;老年胃癌159例臨床分析[J];中國(guó)基層醫(yī)藥;2003年07期

10 王兆軍;老年胃癌患者外科治療112例體會(huì)[J];實(shí)用臨床醫(yī)藥雜志;2003年04期

相關(guān)會(huì)議論文 前10條

1 楊玲;;老年胃癌的臨床病理特點(diǎn)及預(yù)后[A];中華醫(yī)學(xué)會(huì)第八次全國(guó)老年醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2007年

2 王榮茂;;老年胃癌大出血72例臨床分析[A];中國(guó)民政康復(fù)醫(yī)學(xué)第五屆學(xué)術(shù)會(huì)議論文匯編[C];1999年

3 史松濤;朱尉林;甘新君;陳見(jiàn);;老年胃癌患者的臨床特點(diǎn)及外科治療的體會(huì)[A];2005年浙江省腫瘤外科學(xué)術(shù)會(huì)議論文匯編[C];2005年

4 李國(guó)華;呂農(nóng)華;徐萍;陳幼祥;廖旺娣;周小江;舒徐;劉丕;朱萱;;324例老年胃癌的臨床特點(diǎn)[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)消化病學(xué)術(shù)會(huì)議論文匯編（下冊(cè)）[C];2007年

5 王艷;;老年胃癌患者術(shù)后化療期的護(hù)理[A];全國(guó)第五屆老年護(hù)理學(xué)術(shù)交流暨專(zhuān)題講座會(huì)議論文匯編[C];2002年

6 黃國(guó)強(qiáng);張卿;于吉人;;老年胃癌患者術(shù)后早期腸內(nèi)與腸外營(yíng)養(yǎng)的比較研究[A];2012年浙江省腸外腸內(nèi)營(yíng)養(yǎng)學(xué)學(xué)術(shù)年會(huì)論文集[C];2012年

7 徐向陽(yáng);陳莎;黃德珍;周紅梅;李瑩;楊柳;;老年胃癌的螺旋CT診斷[A];第十一次全國(guó)中西醫(yī)結(jié)合影像學(xué)術(shù)研討會(huì)暨全國(guó)中西醫(yī)結(jié)合影像學(xué)研究進(jìn)展學(xué)習(xí)班資料匯編[C];2010年

8 楊晨紅;;老年胃癌患者術(shù)前術(shù)后護(hù)理體會(huì)[A];全國(guó)第八屆老年護(hù)理學(xué)術(shù)交流暨專(zhuān)題講座會(huì)議論文匯編[C];2005年

9 孟玉新;;老年胃癌臨床及圍手術(shù)期處理分析[A];第四屆中國(guó)腫瘤學(xué)術(shù)大會(huì)暨第五屆海峽兩岸腫瘤學(xué)術(shù)會(huì)議論文集[C];2006年

10 陳輝;瞿麗;王國(guó)良;;老年胃癌患者術(shù)后早期應(yīng)用腸內(nèi)營(yíng)養(yǎng)預(yù)防胃癱綜合征的評(píng)價(jià)[A];2007浙江省腸外腸內(nèi)營(yíng)養(yǎng)學(xué)學(xué)術(shù)會(huì)議論文集[C];2007年

相關(guān)重要報(bào)紙文章 前1條

1 中國(guó)中醫(yī)科學(xué)院廣安門(mén)醫(yī)院 劉瑞 李杰;中醫(yī)藥治療老年胃癌的策略[N];中國(guó)醫(yī)藥報(bào);2012年

相關(guān)博士學(xué)位論文 前2條

1 欒復(fù)新;老年胃癌預(yù)后多因素研究[D];中國(guó)人民解放軍軍醫(yī)進(jìn)修學(xué)院;2004年

2 周儒;老年胃癌患者手術(shù)治療風(fēng)險(xiǎn)與療效評(píng)價(jià)及巨噬細(xì)胞相關(guān)集落刺激因子作為新型腫瘤標(biāo)志物的探索[D];復(fù)旦大學(xué);2012年

相關(guān)碩士學(xué)位論文 前9條

1 張玉坤;Mir-1271及RTEF-1在青年及老年胃癌中的表達(dá)及意義[D];鄭州大學(xué);2015年

2 羅文文;鹽酸右美托咪定對(duì)老年胃癌患者圍手術(shù)期IL-1β、IL-6、TNF-α的影響[D];河北醫(yī)科大學(xué);2015年

3 管佳佳;探討老年胃癌患者腹腔鏡輔助遠(yuǎn)端胃大部切除術(shù)后短期療效及并發(fā)癥發(fā)生情況[D];安徽醫(yī)科大學(xué);2015年

4 武苗;七氟醚對(duì)老年胃癌患者圍術(shù)期免疫功能的影響[D];山西醫(yī)科大學(xué);2015年

5 蔡煒龍;老年胃癌患者圍手術(shù)期并發(fā)癥的研究[D];浙江大學(xué);2006年

6 胡苗苗;新疆238例老年胃癌預(yù)后因素分析[D];新疆醫(yī)科大學(xué);2011年

7 魯修明;老年胃癌術(shù)后早期停止胃腸減壓、恢復(fù)腸內(nèi)營(yíng)養(yǎng)的臨床觀察[D];吉林大學(xué);2008年

8 金鐘;老年胃癌患者手術(shù)治療后并發(fā)癥發(fā)生對(duì)生存率、疾病相關(guān)生存質(zhì)量的影響及其影響因素分析[D];新疆醫(yī)科大學(xué);2013年

9 周立宇;老年胃癌手術(shù)后嚴(yán)重并發(fā)癥的相關(guān)因素分析[D];吉林大學(xué);2009年

，

本文編號(hào)：1932693